TY - JOUR
T1 - EndoBridge 2023: highlights and pearls
AU - Yildiz, Bulent Okan
AU - Boguszewski, Cesar Luiz
AU - da Silva Boguszewski, Margaret Cristina
AU - Busetto, Luca
AU - Celik, Ozlem
AU - Fuleihan, Ghada El-Hajj
AU - Goulis, Dimitrios G
AU - Hammer, Gary D
AU - Haymart, Megan R
AU - Kaltsas, Gregory
AU - Law, Jennifer R
AU - Lim, Amanda Yuan Ling
AU - Luger, Anton
AU - Macut, Djuro
AU - McGowan, Barbara
AU - McClung, Michael
AU - Miras, Alexander Dimitri
AU - Patti, Mary Elizabeth
AU - Peeters, Robin P
AU - Pignatelli, Duarte
AU - Saeed, Hamayle
AU - Sipos, Jennifer
AU - Stratakis, Constantine A
AU - Tsoli, Marina
AU - van der Lely, A J
AU - Witchel, Selma F
AU - Yazici, Dilek
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Hellenic Endocrine Society 2024.
PY - 2024/4/15
Y1 - 2024/4/15
N2 - EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11 Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders. As usual, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The abstracts of clinical cases presented by the delegates during oral and poster sessions have been published in JCEM Case Reports. Herein, we provide a paper on highlights and pearls of the meeting sessions covering a wide range of subjects, from thyroid nodule stratification to secondary osteoporosis and from glycemic challenges in post-bariatric surgery to male hypogonadism. This report emphasizes the latest developments in the field, along with clinical approaches to common endocrine issues. The 12th annual meeting of EndoBridge will be held on October 17-20, 2024 in Antalya, Turkey. [Abstract copyright: © 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.]
AB - EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11 Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders. As usual, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The abstracts of clinical cases presented by the delegates during oral and poster sessions have been published in JCEM Case Reports. Herein, we provide a paper on highlights and pearls of the meeting sessions covering a wide range of subjects, from thyroid nodule stratification to secondary osteoporosis and from glycemic challenges in post-bariatric surgery to male hypogonadism. This report emphasizes the latest developments in the field, along with clinical approaches to common endocrine issues. The 12th annual meeting of EndoBridge will be held on October 17-20, 2024 in Antalya, Turkey. [Abstract copyright: © 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.]
KW - Diabetes mellitus
KW - Thyroid
KW - Pituitary
KW - Bone
KW - Adrenal
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=85190408416&partnerID=8YFLogxK
U2 - 10.1007/s42000-024-00549-8
DO - 10.1007/s42000-024-00549-8
M3 - Article
C2 - 38619812
SN - 2520-8721
VL - 23
SP - 183
EP - 204
JO - Hormones (Athens, Greece)
JF - Hormones (Athens, Greece)
IS - 2
ER -